Clinical Trial: Prospective Multicenter Single-Arm Phase II Trial: Adebrelimab Plus Apatinib and Doxorubicin for First-Line Treatment of Advanced Soft Tissue Sarcoma (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective Multicenter Single-Arm Phase II Trial: Adebrelimab Plus Apatinib and Doxorubicin for First-Line Treatment of Advanced Soft Tissue Sarcoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129579

Registration Time: 2026/08/06

Type: Interventional study

Primary Sponsor: Fudan University Shanghai Cancer Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337015

Published by HT Digital Content Services with permission from Health Daily Digest....